Navigation Links
CSSi, the Leader in Global Patient Recruitment Solutions for Clinical Trials Industry, Rolls Out Redesigned Website: www.CSSiEnroll.com
Date:1/9/2014

GLEN BURNIE, Md., Jan. 9, 2014 /PRNewswire/ -- CSSi, the leader in global patient recruitment solutions for the clinical research industry, is proud to announce the launch of its redesigned website, www.CSSiEnroll.com. The new site reflects the evolution of the company from focusing on site performance to a global patient recruitment provider motivated to provide innovative enrollment solutions to sponsors and CROs for clinical trials.

The fusion of style and content provides enhanced details for sponsor companies, CROs and investigative sites who are seeking targeted data on CSSi's strategic and innovative services; these services range from patient recruitment campaign strategies to full-service enrollment planning, including study start-up, creative design, media planning and digital messaging.  

Clients will also find information on Local Enrollment Specialists™ (LES™), a proprietary and unique service offering of CSSi, which is a key element of their successful global recruitment programs. The CSSi LES™ team members are located in over 40 countries and on every continent. They are experienced in patient recruitment, have a strong knowledge of local ethics committees and regulatory bodies, and speak the local language of the sites which they are supporting.

"CSSi has been an integral part of the patient recruitment industry for quite a while, and we have always stood out by offering more than just recruitment services," stated Chris Trizna, President. "Take a look at our case studies," added Trizna. "Our clients can see where CSSi's involvement has a unique ability to positively impact enrollment, not just responses, referrals or recruitment."

Trizna further elaborated, "The re-launching of the CSSi website is the next step in the growth of our company and gives us a platform to highlight our unique products
'/>"/>

SOURCE CSSi
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. A Unique Collaboration of Life Science Leaders, including the Fight Against Cancer Innovation Trust, MaRS Innovation Ventures Trust and MaRS Phase II Investment Trust, has formed Triphase Accelerator Corporation to be an Oncology Development Accele
2. Schneider Electric reinforces its position as a leader in solar utility scale market
3. EY Global Life Sciences Center Announces New Appointments to Its Leadership Team
4. Bioentrepreneurship Leader Joins UM Ventures Team
5. Intrexon Strengthens Leadership in Companys Rapidly Growing Health Sector
6. Five Key Mega Trends in Nature Inspired Innovation: A Thought Leadership Video by Dr. Sanjay Mazumdar
7. Excelera Corp. Announces Commitments by National Leaders
8. Enteris BioPharma Forms Scientific Advisory Board to Enhance Leadership in Oral Delivery of Peptide and Small Molecule Drugs
9. Everest Group Recognizes TCS as a Global Leader and Star Performer in Life Sciences IT Outsourcing
10. Genelux, a Leader in the Emerging Oncolytic Virotherapy Field, Receives Significant Industry Honor from Elsevier Business Intelligence, Identifying GL-ONC1 as One of 2013s Top Oncology Projects to Watch
11. BioSpace Spotlights Washington State Biotech Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... NC (PRWEB) March 30, 2015 ... are pleased to announce the formation of VaxCorps, ... research centers specializing in the conduct of vaccine ... VaxCorps clinical sites have successfully conducted over ... experience in seasonal and pandemic influenza as well ...
(Date:3/30/2015)... US-Australian drug discovery company, Novogen Ltd, (ASX:NRT; NASDAQ: ... University, on March 27 released pre-clinical data on experimental ... oral presentation by Professor Gil Mor MD ... Annual Scientific Meeting of the Society of Reproductive ... In both in vitro and in animal ...
(Date:3/30/2015)... BELLINGHAM, Washington, USA (PRWEB) March 29, 2015 ... Europe and the United States and plenary talks by ... for SPIE Optics + Optoelectronics next month ... 700 technical presentations in 17 conferences alongside a two-day ... optics and photonics , the event will run 13-16 ...
(Date:3/29/2015)... 29, 2015  Caris Life Sciences® today announced ... Molecular Intelligence®, the company,s panomic, comprehensive tumor profiling ... several rare and difficult to treat gynecological cancers ... potential to improve patient outcomes. These studies were ... Society of Gynecologic Oncology (SGO) 2015 Annual Meeting ...
Breaking Biology Technology:PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks 2Yale University and Novogen Release Data on Cantrixil Mode of Action 2Yale University and Novogen Release Data on Cantrixil Mode of Action 3Yale University and Novogen Release Data on Cantrixil Mode of Action 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 2Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 4
... ... Surgeons directory service and website at www.TrustedLASIKSurgeons.com to provide a ... qualified LASIK surgeon who can help improve their chances of attaining 20-20 ... screening process ensuring that only those who are among the best in ...
... SAN FRANCISCO, Sept. 22 OrbusNeich today announced that the ... that the company,s Genous Bio-engineered R stent is safe and effective ... diabetes mellitus. , , The study evaluated 4,987 ... (TVF) rate of 8.1 percent at 12 months with a follow-up ...
... ... the state,s economy were confirmed by two recent economic reports issued by the Hawaii ... Leroy Laney. , ... Honolulu, HI (Vocus) Sept. 22, 2009 -- The seed industry,s significant contributions to the ...
Cached Biology Technology:LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 2LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 3LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 4LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 5LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 6LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory 7Final 12 Month Clinical Data from 5,000 Patients in Worldwide e-HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 2Final 12 Month Clinical Data from 5,000 Patients in Worldwide e-HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 3Final 12 Month Clinical Data from 5,000 Patients in Worldwide e-HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 4Economic Strength of Hawaii Seed Crop Industry Confirmed by Recent Reports 2Economic Strength of Hawaii Seed Crop Industry Confirmed by Recent Reports 3
(Date:3/31/2015)... , March 31, 2015   Guidepoint , a ... of the Post-Surgical Pain Management TRACKER, part of the ... usage trends in the medical device and therapeutics markets. ... data including treatment volumes, market share, and adoption rates ... associated with joint surgery. The Post-Surgical Pain ...
(Date:3/24/2015)... March 24, 2015   NexID Biometrics LLC, ... security-authentication needs, today announced the beginning of shipments of ... The company, based in Potsdam, ... three-day Connect:ID Expo, which began here today at the ... version 2.0 of its SDK boosts the accuracy rate ...
(Date:3/23/2015)... Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... on CNBC television starting March 30 th . ... in New York markets. ... are excited about our new ad campaign following the recent ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3
... is enabling researchers to study the effectiveness of drugs ... the University of Leeds,s Faculty of Biological Sciences will ... mutation linked to schizophrenia and autism and seeing how ... fully understand how the drugs used to treat schizophrenia ...
... Toxin Does Not Affect MRSA-Induced Pneumonia ... the Center for Molecular and Translational Human Infectious Diseases ... Texas has demonstrated that the cytotoxin Paton-Valentine leukocidin (PVL) ... pneumonia. Their report can be found ...
... WASHINGTON The Proceedings of the National Academy of ... papers to receive the 2009 Cozzarelli Prize, an award ... the National Academy of Sciences. Papers selected for the ... published by PNAS in 2009 and represent the ...
Cached Biology News:Research builds on genetic link to autism and schizophrenia 2Tips from the American Journal of Pathology 2Tips from the American Journal of Pathology 3Tips from the American Journal of Pathology 4Tips from the American Journal of Pathology 5PNAS announces six 2009 Cozzarelli Prize recipients 2
... Continuing a tradition of progressive centrifuge ... CL3 series. The Centra-CL3 and Centra-CL3R (refrigerated) ... todays laboratory., Quality Control Over Sample ... and lock up to 99 protocols and ...
p230 trans Golgi Purified Anti-Human clone 15, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
... I Large (Klenow) Fragment, Exonuclease Minus, is ... the 5´→3´ and the 3´→5´ exonuclease activities ... I (1,2). It is used for random ... amplification (5). Klenow Fragment, Exonuclease Minus, will ...
... PGE2 is one of several isoprostanes produced from ... potent renal vasoconstrictor in the rat. 8-iso PGE2 ... values of 0.5 and 5 µM, respectively. When ... at a concentration of 4 mg/kg/min, 8-iso PGE2 ...
Biology Products: